Skip to main content

Table 5 Sensitivity analysis: Estimated effects in the PP data set and the imputed data sets

From: Multiple treatment comparisons in a series of anti-malarial trials with an ordinal primary outcome and repeated treatment evaluations

  PP dataset Imputed dataset
Covariates OR 95% CI OR 95% CI
Study 3-1 1.11 0.16 11.58 3.72 0.70 19.68
Study 4-1 2.17 0.29 16.52 2.06 0.43 9.92
Study 5-1 0.51 0.07 3.857 2.23 0.05 9.03
AQ 1.47 0.24 8.89 1.84 0.39 8.64
AMLM 3.84 0.47 31.35 5.40 0.88 33.31
ASCD 0.29 0.02 3.30 0.41 0.05 3.27
ASSP 4.88 0.76 31.20 3.95 0.80 16.61
DHPP 17.89* 4.70 67.99 15.64* 3.59 68.10
Day21-14 0.05* 0.01 0.21 0.02* 0.01 0.05
Day28-14 0.05* 0.01 0.41 0.02* 0.01 0.04
  1. Model M3, study # 2 excluded. OR: Odds Ratio, 95% CI: confidence interval. *: significant at the 5% level.